Neuronetics, Inc. (FRA:NRC)
Germany · Delayed Price · Currency is EUR 1.250
+0.036 (2.97%)
At close: Dec 1, 2025
Neuronetics Company Description
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.
Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Neuronetics, Inc.
| Country | United States |
| Founded | 2001 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 716 |
| CEO | Keith Sullivan |
Contact Details
Address: 3222 Phoenixville Pike Malvern, Delaware 19355 United States | |
| Phone | 610 640 4202 |
| Website | neurostar.com |
Stock Details
| Ticker Symbol | NRC |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Keith Sullivan | Chief Executive Officer |
| Steven Pfanstiel | Chief Financial Officer |
| Jeffrey Jones | Chief Operating Officer |